Fluicell AB (publ) (STO:FLUI)
Sweden · Delayed Price · Currency is SEK 34.00
+0.90 (2.72%)
Jul 3, 2026, 4:48 PM CET
Fluicell AB Market Cap
Fluicell AB has a market cap or net worth of 46.71 million as of July 2, 2026. Its market cap has increased by 236.63% in one year.
Market Cap
46.71M
Enterprise Value
45.41M
Revenue
20.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.00
Market Cap Chart
Since April 18, 2018, Fluicell AB's market cap has decreased from 113.77M to 46.71M, a decrease of -58.95%. That is a compound annual growth rate of -10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 46.71M | 240.00% |
| Dec 30, 2025 | 13.74M | -30.31% |
| Dec 30, 2024 | 19.71M | 14.60% |
| Dec 29, 2023 | 17.20M | -54.87% |
| Dec 30, 2022 | 38.12M | -85.77% |
| Dec 30, 2021 | 267.82M | 14.56% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spago Nanomedical AB | 92.61M |
| Scandinavian ChemoTech AB | 92.40M |
| Annexin Pharmaceuticals AB | 85.06M |
| AcouSort AB | 83.17M |
| Alzinova AB | 81.82M |
| 2cureX AB | 71.78M |
| Pila Pharma AB | 56.65M |
| Modus Therapeutics Holding AB | 46.46M |